Frontlight ResearchEarly access
Trial site
Taipei
- 14running trials
- 8closed trials
The trials here
What the 22 trials at this site are about, from their registry records.
- Conditions
- Atopic dermatitis (eczema)5 trials
- Haemophilia4 trials
- CIDP (chronic inflammatory demyelinating polyneuropathy)3 trials
- Fabry disease2 trials
- Multiple myeloma2 trials
- Pompe disease2 trials
- Chronic spontaneous urticaria1 trial
- Metastatic breast cancer1 trial
- Sjögren's disease1 trial
- Phase
- Phase 312 trials
- Phase 24 trials
- Phase 2/31 trial
- Phase 41 trial
- Status
- Active, not recruiting10 trials
- Completed7 trials
- Recruiting3 trials
- Enrolling by invitation1 trial
- Terminated1 trial
- Lead sponsor
- Sanofi21 trials
- Genzyme, a Sanofi Company1 trial
Running trials
Recruiting
Enrolling by invitation
Long-term Safety and Efficacy Study of Riliprubart in Participants With CIDP
Active, not recruiting
Recruiting
Active, not recruiting
Active, not recruiting
Recruiting
Active, not recruiting
Active, not recruiting
Active, not recruiting
Active, not recruiting
Active, not recruiting
Active, not recruiting
Active, not recruiting
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- CIDP (chronic inflammatory demyelinating polyneuropathy)2 recruiting
- Haemophilia1 recruiting
Closed trials
Completed
Completed
Agalsidase Beta Long-Term Treatment Outcome for Fabry Disease Patients With IVS4 Mutation in Taiwan
Completed
Completed
Completed
Completed
Terminated
Completed
Site data: ClinicalTrials.govUpdated 18 Nov 2026